Wikidata

(Q62110923)

English

Dalteparin to Prevent Complications in Cancer Patients Receiving Chemotherapy Through a Catheter

clinical trial

In more languages

Statements

title
A Phase III Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effects of Fragmin (5,000 IU Subcutaneously) in Preventing Catheter-Related Complications When Given Daily to Cancer Patients With Central Venous Catheters (English)
0 references
medical condition
lymphoma
0 references
syndrome
0 references
leukemia
0 references
multiple myeloma
0 references
plasmacytoma
0 references
start time
April 2000
0 references
end time
November 2000
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q62110923&oldid=2149192393"